We hypothesized that genes with larger expression increase post-ICB in LS characterize the activity of immune evasion factors while those in HS/CB reflect anti-tumor activity or emerging adaptive resistance to anti-PD1. This evidence concerns the gene PDCD1 and neoplasm.